Actually, it's only $140 million.
It's really to leverage what we've already started, but really to establish CDRD firmly as a national organization with an expanded search team that we can really have people on the ground all across the country, and also to really invest in some of the projects.
Drug development is a very time-consuming and complicated process. You have to expect a lot of attrition. It's science and sometimes the experiments don't work out. You need a lot of shots on goal to find the successes that will provide not only the economic success at the time but the self-sustaining aspect, which we built into our model right from the beginning. We realized that, at the start-up period, if we can invest in technologies, then hopefully there will be a couple of home runs in there that will fund our continued operations after a start-up period.